Sensei Biotherapeutics, Inc. logo

Sensei Biotherapeutics, Inc.

NASDAQ:SNSE

Overview | Financials
Company Name Sensei Biotherapeutics, Inc.
Symbol SNSE
Currency USD
Price 0.519
Market Cap 13,053,421
Dividend Yield 0%
52-week-range 0.384 - 1.94
Industry Biotechnology
Sector Healthcare
CEO Mr. John K. Celebi M.B.A., MBA
Website https://www.senseibio.com

An error occurred while fetching data.

About Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment

Related Stocks

Cardiff Oncology, Inc. logo

Cardiff Oncology, Inc.

CRDF

3.74 USD

Aligos Therapeutics, Inc. logo

Aligos Therapeutics, Inc.

ALGS

9.48 USD

Reneo Pharmaceuticals, Inc. logo

Reneo Pharmaceuticals, Inc.

RPHM

18.2 USD

Cryo-Cell International, Inc. logo

Cryo-Cell International, Inc.

CCEL

7.37 USD

Vaccinex, Inc. logo

Vaccinex, Inc.

VCNX

3.24 USD

Daxor Corporation logo

Daxor Corporation

DXR

9.133 USD

Financials

Numbers are in millions USD

Numbers are in millions USD